Clinical development of photodynamic agents and therapeutic applications.
Rengarajan BaskaranJunghan LeeSu-Geun YangPublished in: Biomaterials research (2018)
Here, we discuss up-to-date information on FDA-approved photodynamic agents, the clinical benefits of these agents. However, PDT is still dearth for the treatment of diseases in specifically deep tissue cancer. Next generation PS will be addressed in the future for PDT. We also provide clinical unmet need for the design of new photosensitizers.